Loading...

FITC anti-mouse CD3 Antibody

Pricing & Availability
Clone
17A2 (See other available formats)
Regulatory Status
RUO
Other Names
T cell antigen receptor complex, T3
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
17A2
C57BL/6 splenocytes stained with 17A2 FITC and 145-2C11 PE
  • 17A2
    C57BL/6 splenocytes stained with 17A2 FITC and 145-2C11 PE
Compare all formats See FITC spectral data
Cat # Size Price Save
100203 50 µg ¥7,920
100204 500 µg ¥26,440
Description

CD3, also known as T3, is a member of the Ig superfamily and primarily expressed on T cells, NK-T cells, and at different levels on thymocytes during T cell differentiation. CD3 is composed of CD3ε, δ, γ and ζ chains. It forms a TCR complex by associating with TCR α/β or γ/δ chains. CD3 plays a critical role in TCR signal transduction, T cell activation, and antigen recognition by binding the peptide/MHC antigen complex

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
γδTCR-positive T-T hybridoma D1
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Additional reported application (for relevant formats) include: spatial biology (IBEX)1,2.

Application References

(PubMed link indicates BioLegend citation)
  1. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  2. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Petrova T, et al. 2020. Sci Rep. 10:3479. PubMed
  2. Zhang H, et al. 2021. Front Immunol. 12:644520. PubMed
  3. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  4. Lee JH, et al. 2022. EBioMedicine. 77:103903. PubMed
  5. Zhu Y, et al. 2022. Nat Commun. 13:4282. PubMed
  6. Harel M, et al. 2020. J Immunol. 205:1167. PubMed
  7. Bruno MEC, et al. 2022. J Cell Physiol. 237:706. PubMed
  8. Pei J, et al. 2022. J Virol. 96:e0194221. PubMed
  9. Li X, et al. 2022. J Clin Invest. 132: . PubMed
  10. Meng J, et al. 2022. Cell Rep. 38:110492. PubMed
  11. Corral D, et al. 2022. Cell Rep. 39:110715. PubMed
  12. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  13. Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed
  14. Wu J, et al. 2023. Bioact Mater. 20:259. PubMed
  15. Shen CY, et al. 2022. Pharmaceutics. 14: . PubMed
  16. Brigo N, et al. 2022. Bio Protoc. 12:e4440. PubMed
  17. Hong Y, et al. 2022. J Leukoc Biol. 112:425. PubMed
  18. Mugarza E, et al. 2022. Sci Adv. 8:eabm8780. PubMed
  19. Xie DH, et al. 2022. Med Phys. 49:6728. PubMed
  20. Gong F, et al. 2023. Adv Healthc Mater. 12:e2201771. PubMed
  21. Gao Y, et al. 2022. Cell Res. 32:1086. PubMed
  22. Chen Y, et al. 2023. Adv Healthc Mater. 12:e2202085. PubMed
  23. Wei M, et al. 2022. Front Immunol. 13:1017574. PubMed
  24. Liang Y, et al. 2022. Theranostics. 12:7729. PubMed
  25. You Q, et al. 2023. Adv Mater. 35:e2204910. PubMed
  26. Kim HI, et al. 2022. Molecules. 27: . PubMed
  27. Shi C, et al. 2023. Nat Nanotechnol. 18:86. PubMed
  28. Yang H, et al. 2023. Cell Death Differ. 30:560. PubMed
  29. Yu J, et al. 2022. Nat Commun. 13:7903. PubMed
  30. Schepers M, et al. 2023. Brain Behav Immun. 109:1. PubMed
  31. Ding L, et al. 2023. J Clin Invest. 133: . PubMed
  32. Peng Q, et al. 2023. EMBO Rep. 24:e56034. PubMed
  33. Jin SM, et al. 2023. Nat Nanotechnol. :. PubMed
  34. Liu H, et al. 2023. Cell Death Differ. :. PubMed
  35. Tsioti I, et al. 2023. J Neuroinflammation. 20:25. PubMed
  36. Gon Y, et al. 2023. PLoS One. 18:e0279389. PubMed
  37. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  38. Zhang W, et al. 2022. Dev Cell. 57:329. PubMed
  39. Meacham CE, et al. 2022. Nat Cell Biol. 24:697. PubMed
  40. Reticker-Flynn NE, et al. 2022. Cell. 185:1924. PubMed
  41. Bruggemann TR, et al. 2022. iScience. 25:105185. PubMed
  42. Harsha Krovi S, et al. 2020. Nat Commun. 4.790277778. PubMed
  43. Dai L, et al. 2020. Cell. 182(3):722-733.e11. PubMed
  44. Xing J, et al. 2021. Cell Reports. 35(12):109205. PubMed
  45. Zaman R, et al. 2021. Immunity. :. PubMed
  46. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  47. Jiang W, et al. 2017. Sci Rep. 7:6501. PubMed
  48. Zimmerman SM, et al. 2022. Oncogene. 41:4983. PubMed
  49. Peng J, et al. 2023. Am J Reprod Immunol. 89:e13678. PubMed
  50. Chen H, et al. 2023. Nat Commun. 14:941. PubMed
  51. Wang F, et al. 2023. Int J Mol Sci. 24:. PubMed
  52. Liu HJ, et al. 2023. Nat Commun. 14:1214. PubMed
  53. Guo D, et al. 2023. Cell Biosci. 13:51. PubMed
  54. Dang YZ, et al. 2023. Neoplasma. 70:123. PubMed
  55. Wang Y, et al. 2023. Front Bioeng Biotechnol. 11:1128268. PubMed
  56. Sambandam A, et al. 2023. Heliyon. 9:e14238. PubMed
  57. Masle-Farquhar E, et al. 2023. Front Immunol. 14:1095257. PubMed
  58. Tao Q, et al. 2023. Microbiol Spectr. :e0522922. PubMed
  59. Tan X, et al. 2023. Adv Sci (Weinh). 10:e2206768. PubMed
  60. Zhang YN, et al. 2023. Nat Commun. 14:1985. PubMed
  61. Ito M, et al. 2023. Sci Rep. 13:5939. PubMed
  62. Huang T, et al. 2023. Front Immunol. 14:1124152. PubMed
  63. Kuang C, et al. 2023. Nat Commun. 14:2093. PubMed
  64. Zuo B, et al. 2023. Clin Transl Oncol. . PubMed
  65. Bhaskar A, et al. 2023. iScience. 26:106644. PubMed
  66. Wang K, et al. 2023. Nat Commun. 14:2950. PubMed
  67. Wang D, et al. 2023. Nat Commun. 14:2943. PubMed
  68. Xie J, et al. 2023. Mol Ther Oncolytics. 29:61. PubMed
  69. Feng X, et al. 2023. Nat Commun. 14:3208. PubMed
  70. Zeng S, et al. 2023. Front Oncol. 13:1171926. PubMed
  71. Lan Y, et al. 2023. iScience. 26:106817. PubMed
  72. Yang QC, et al. 2023. iScience. 26:106916. PubMed
  73. Gawish R, et al. 2022. Elife. 11:. PubMed
  74. Qiao Y, et al. 2021. Oncoimmunology. 10:1947569. PubMed
  75. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  76. Manukian G, et al. 2021. Int J Radiat Oncol Biol Phys. 110:1341. PubMed
  77. Jiang Q, et al. 2022. Theranostics. 12:59. PubMed
  78. Wilhelm J, et al. 2021. J Control Release. 329:353. PubMed
  79. Ford K, et al. 2020. Cancer Res. 80:1846. PubMed
  80. Delvecchio FR, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:1543. PubMed
  81. Zhang R, et al. 2021. Cell Mol Immunol. 18:1222. PubMed
  82. Tang L, et al. 2021. Oncol Lett. 22:605. PubMed
  83. Kim D, et al. 2021. Nanomicro Lett. 13:31. PubMed
  84. Miller CM, et al. 2020. J Virol. 94:00:00. PubMed
  85. Boyd DF, et al. 2020. Nature. 587:466. PubMed
  86. Wu X, et al. 2012. Biochem Pharmacol. 84:1164. PubMed
  87. Lin W, et al. 2020. Theranostics. 10:4871. PubMed
  88. Turner JA, et al. 2020. Immunity. 53:1202. PubMed
  89. Jiang W, et al. 2021. Oncol Lett. 22:625. PubMed
  90. Choi YY, et al. 2021. Cell Death Dis. 12:826. PubMed
  91. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  92. Zhang S, et al. 2022. Acta Pharm Sin B. 12:3124. PubMed
  93. Steubing RD, et al. 2022. Brain Behav Immun Health. 24:100493. PubMed
  94. Mei S, et al. 2022. Front Immunol. 13:911164. PubMed
  95. Lu H, et al. 2021. Autophagy. 17:2511. PubMed
  96. Bao H, et al. 2020. Mol Med Rep. 4.675. PubMed
  97. Du Q, et al. 2019. Front Microbiol. 10:2050. PubMed
  98. Song C, et al. 2019. Nat Commun. 10:3745. PubMed
  99. Liu QZ, et al. 2018. Front Immunol. 1.131944444. PubMed
  100. Chou YJ, et al. 2020. Sci Rep. 10:8422. PubMed
  101. Bromley SK, et al. 2020. Cell Reports. 32(9):108085. PubMed
  102. Diao L, et al. 2022. iScience. 25:105511. PubMed
  103. Bangs DJ, et al. 2022. Cell Rep. 38:110266. PubMed
  104. Huang Y, et al. 2021. Radiother Oncol. 162:34. PubMed
  105. Zhao J, et al. 2022. J Nanobiotechnology. 20:62. PubMed
  106. Ren J, et al. 2021. Theranostics. 11:304. PubMed
  107. Tan X, et al. 2021. Front Oncol. 11:768222. PubMed
  108. Oliva Chávez AS, et al. 2021. Nat Commun. 12:3696. PubMed
  109. Liu Q, et al. 2021. Cell Death Dis. 12:240. PubMed
  110. Fu Y, et al. 2020. Mol Ther. 1214:28. PubMed
  111. Sun CC, et al. 2020. Genome Med. 0.553472222. PubMed
  112. Schmidleithner L et al. 2019. Immunity. 50(5):1232-1248 . PubMed
  113. Dolgova EV, et al. 2022. Int J Mol Sci. 23:. PubMed
  114. Mostafavi H, et al. 2022. PLoS Pathog. 18:e1010185. PubMed
  115. Sala D, et al. 2022. Mol Ther Methods Clin Dev. 25:170. PubMed
  116. Starkl P, et al. 2020. Immunity. 53(4):793-804.e9. PubMed
  117. Antonia O Cuff et al. 2017. Wellcome open research. 2:39 . PubMed
  118. Davis FM, et al. 2019. Arterioscler Thromb Vasc Biol. 39:2353. PubMed
  119. Pham THM, et al. 2020. Cell Host & Microbe. 27(1):54-67.e5.. PubMed
  120. Lesmeister M, et al. 2005. Reprod Biol Endocrinol. 29:74. PubMed
  121. Deng P, et al. 2022. Cells. 11:. PubMed
  122. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  123. Zhan Y, et al. 2021. JCI Insight. 6:. PubMed
  124. Yu AI, et al. 2020. Cell Rep. 107471:31. PubMed
  125. Jiang S, et al. 2020. Scand J Immunol. e12867:91. PubMed
  126. Perner C, et al. 2020. Immunity. 53(5):1063-1077.e7. PubMed
  127. White C, et al. 2014. J Immunol. 193:5933. PubMed
  128. Chen Y, et al. 2012. PLoS One. 7:e47190. PubMed
  129. Ning X, et al. 2019. Mol Cell. 74:19. PubMed
  130. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  131. Dang Y, et al. 2022. Cancer Cell Int. 22:88. PubMed
  132. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  133. Geng T, et al. 2022. Methods Mol Biol. 2585:71. PubMed
  134. Lee M, et al. 2014. PLoS One. 9:112666. PubMed
  135. Mingozzi F, et al. 2016. EMBO Mol Med. 8: 1039 - 1051. PubMed
  136. Solanki A, et al. 2018. Development. 145. PubMed
  137. Shields BD, et al. 2019. Cancer Res. 79:1113. PubMed
  138. Carr RM, et al. 2021. Nat Commun. 12:2901. PubMed
  139. Pervaiz N, et al. 2021. Pigment Cell Melanoma Res. 34:918. PubMed
  140. Sun Y, et al. 2022. Nat Commun. 13:3916. PubMed
  141. Zhang B, et al. 2021. Nat Biomed Eng. 5:1288. PubMed
  142. Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed
  143. Kimball AS et al. 2019. Immunity. 51(2):258-271 . PubMed
  144. Naing A et al. 2019. Cell reports. 26(5):1242-1257 . PubMed
  145. Yang S, et al. 2019. Nat Commun. 10:2782. PubMed
  146. Littwitz-Salomon E, et al. 2021. Nat Commun. 12:5376. PubMed
  147. Hanasoge Somasundara AV, et al. 2021. Cell Rep. 37:110099. PubMed
  148. Shi R, et al. 2022. Theranostics. 12:875. PubMed
  149. Jie X, et al. 2022. J Immunother Cancer. 10:. PubMed
  150. Chen Q, et al. 2016. Nat Commun. 7:13193. PubMed
  151. Bogie JF, et al. 2020. Ther Adv Chronic Dis. 11:2040622320947378. PubMed
  152. Li Y, et al. 2020. Cell Stem Cell. 27(5):732-747.e7. PubMed
  153. Omori S, et al. 2021. Cell Reports. 34(6):108734. PubMed
  154. Wang X, et al. 2018. Mol Med Rep. 17:1660. PubMed
  155. Lee JS et al. 2018. Cell. 174(6):1559-1570 . PubMed
  156. Comazzetto S et al. 2018. Cell stem cell. 24(3):477-486 . PubMed
  157. Ding Y, et al. 2022. Cell Death Dis. 13:996. PubMed
  158. Tang X, et al. 2022. Cell Rep. 41:111673. PubMed
  159. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  160. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  161. Zhou H, et al. 2022. Oncoimmunology. 11:2057892. PubMed
  162. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  163. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  164. Koren E, et al. 2022. Nat Commun. 13:4628. PubMed
  165. Zhang C, et al. 2022. Nat Commun. 13:3468. PubMed
  166. Chen X, et al. 2021. Cell Rep. 37:109991. PubMed
  167. Ye P, et al. 2022. Front Cardiovasc Med. 8:810477. PubMed
  168. Zuo S, et al. 2021. J Immunother Cancer. 9:. PubMed
  169. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  170. Harb H, et al. 2021. Immunity. 54(6):1186-1199.e7. PubMed
  171. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  172. Elahi S, et al. 2020. Stem Cell Res. 43:101710. PubMed
  173. Akhter N, et al. 2016. J Biol Chem. 291: 23672 - 23680. PubMed
  174. Huang B, et al. 2015. PLoS One. 10: 0134715. PubMed
  175. Markey K, et al. 2014. J Immunol. 192:5426. PubMed
  176. Sreekumar PG, et al. 2018. J Control Release. 283:94. PubMed
  177. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  178. Li W, et al. 2019. Nat Commun. 10:3349. PubMed
  179. Xu X, et al. 2018. Cell. 175:1336. PubMed
  180. Reismann D, et al. 2017. Nat Commun.. 10.1038/s41467-017-01538-9. PubMed
  181. Ishidome T et al. 2017. EBioMedicine. 22:89-99 . PubMed
  182. Liu W, et al. 2021. Cell Death Discov. 7:136. PubMed
  183. França TT, et al. 2021. JCI Insight. 6:. PubMed
  184. Carbone C, et al. 2021. J Immunother Cancer. 9:. PubMed
  185. Shannon JP, et al. 2021. STAR Protoc. 2:100790. PubMed
  186. Sun C, et al. 2022. J Adv Res. 35:71. PubMed
  187. Du J, et al. 2012. Stem Cells. 30:1447. PubMed
  188. Weinheimer-Haus E, et al. 2014. PLoS One. 9:91355. PubMed
  189. Zheng L, et al. 2020. Front Oncol. 10:531131. PubMed
  190. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  191. Moon HG et al. 2018. Immunity. 49(2):275-287 . PubMed
  192. Ren W, et al. 2018. Mucosal Immunol. 12:531. PubMed
  193. Yang Z, et al. 2021. Onco Targets Ther. 14:4239. PubMed
  194. Puigdelloses M, et al. 2021. J Immunother Cancer. 9:. PubMed
  195. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  196. Port JR, et al. 2020. J Virol. 94:. PubMed
  197. Rashid MH, et al. 2021. Oncol Rep. 45:1171. PubMed
  198. Li Y, et al. 2021. Cell Death Dis. 12:1001. PubMed
  199. Alsina-Sanchis E, et al. 2020. Mol Cancer Res. . PubMed
  200. Shannon JP, et al. 2021. Immunity. 54(2):276-290.e5. PubMed
  201. Choi EW, et al. 2020. Sci Rep. 10:12001. PubMed
  202. Yu X, et al. 2019. Nat Commun. 10:574. PubMed
  203. Cohen M et al. 2018. Cell. 175(4):1031-1044 . PubMed
  204. Ma W, et al. 2017. Cell Death & Disease. 10.1038/cddis.2017.47. PubMed
  205. Yu H, et al. 2021. Front Oncol. 11:736882. PubMed
  206. Xiao Y, et al. 2022. Nat Commun. 13:758. PubMed
  207. Zhang R, et al. 2022. Front Pharmacol. 13:870848. PubMed
  208. Ali S, et al. 2021. PLoS One. 16:e0246646. PubMed
  209. Yang Z, et al. 2021. Nat Commun. 12:4852. PubMed
  210. Pandit M, et al. 2021. Eur J Immunol. 51:1461. PubMed
  211. Lingegowda H, et al. 2022. Front Reprod Health. 3:726936. PubMed
  212. Zhang W, et al. 2019. Mar Drugs. 0.845138889. PubMed
  213. Nowlan B, et al. 2019. Haematologica. 105:71. PubMed
  214. Zhang W, et al. 2020. Nat Commun. 11:1187. PubMed
  215. Yi H, et al. 2021. Front Immunol. 12:719189. PubMed
  216. Qi J, et al. 2021. Nat Commun. 12:4755. PubMed
  217. Bent EH, et al. 2021. Nat Commun. 12:6218. PubMed
  218. Zhang YN, et al. 2021. Sci Adv. 7:eabj3107. PubMed
  219. Murdock BJ, et al. 2021. JCI Insight. 6:. PubMed
  220. Robertson TF, et al. 2021. J Cell Biol. 220:. PubMed
  221. Mohammadi MR, et al. 2021. Commun Biol. 4:685. PubMed
  222. Li X, et al. 2021. Cell Death Dis. 12:314. PubMed
  223. Wang Z, et al. 2021. Acta Pharm Sin B. 694:11. PubMed
  224. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  225. Wu L, et al. 2020. Cell Rep. 33:108327. PubMed
  226. Zan H, et al. 2017. Nat Commun. 8:14244. PubMed
  227. Cabrera-Perez J, et al. 2016. J Immunol. 197: 1692 - 1698. PubMed
  228. Kang J, Lee J, Chang J 2016. PLoS One. 11: 0157015. PubMed
  229. Cabrera-Perez C, et al. 2015. J Immunol . 194:1609-20. PubMed
  230. He J, et al. 2020. Evid Based Complement Alternat Med. 2020:5637507. PubMed
  231. Roy S, et al. 2019. Front Immunol. 2.404166667. PubMed
  232. Scally S, et al. 2017. Nat Commun. . 10.1038/s41467-017-01924-3. PubMed
  233. Zhang X, et al. 2021. Nat Commun. 12:4536. PubMed
  234. Smith-Díaz CC, et al. 2021. Front Oncol. 11:709543. PubMed
  235. Tsai HI, et al. 2021. EMBO Mol Med. 13:e12834. PubMed
  236. Wang J, et al. 2022. Clin Transl Med. 12:e718. PubMed
  237. Lai Y, et al. 2022. Clin Transl Med. 12:e999. PubMed
  238. Zhang J, et al. 2022. Biomater Res. 26:44. PubMed
  239. Li M, et al. 2021. Br J Pharmacol. 178:2617. PubMed
  240. Yang YS, et al. 2022. Nat Commun. 13:6175. PubMed
  241. Chen X, et al. 2019. Med Sci Monit. 25:5389. PubMed
  242. Chen Y, et al. 2022. Nat Commun. 13:4468. PubMed
  243. Nam J, et al. 2021. Adv Ther (Weinh). 4:. PubMed
  244. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  245. Zhou H, et al. 2021. Cell Death Discov. 7:332. PubMed
  246. Yang Z, et al. 2021. Nat Commun. 12:4299. PubMed
  247. van den Berk P, et al. 2020. Cell Rep. 33:108533. PubMed
  248. Harb H, et al. 2020. Nat Immunol. 1359:21. PubMed
  249. Campolo M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  250. Baumann D, et al. 2020. Nat Commun. 1.969444444. PubMed
  251. Chen C, et al. 2020. Front Cell Neurosci. 14:8. PubMed
  252. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  253. Jiang Y, et al. 2021. Nat Commun. 12:742. PubMed
  254. Magee JA, et al. 2021. Stem Cell Reports. 16:20. PubMed
  255. Fujimoto M, et al. 2022. Nat Commun. 13:5408. PubMed
  256. Cané S, et al. 2021. J Immunother Cancer. 9:. PubMed
  257. Ravindran Menon D, et al. 2021. Pharmaceuticals (Basel). 14:. PubMed
  258. Le QV, et al. 2022. Bioact Mater. 15:160. PubMed
  259. Aulova KS, et al. 2022. Molecules. 27:. PubMed
  260. Yang N, et al. 2022. Nat Commun. 13:2336. PubMed
  261. Xu Y, et al. 2016. Nat Commun. 7:12073. PubMed
  262. Zheng DW, et al. 2020. Nat Commun. 3.865972222. PubMed
  263. Jia H, et al. 2018. Int J Oncol. 53:949. PubMed
  264. Chao Y, et al. 2020. Sci Adv. 6:eaaz4204. PubMed
  265. Tao Z, et al. 2022. Cells. 11:. PubMed
  266. Tang T, et al. 2022. J Immunother Cancer. 10:. PubMed
  267. Zhou Y, et al. 2022. Theranostics. 12:5488. PubMed
  268. Chen LH, et al. 2021. Sci Rep. 11:19478. PubMed
  269. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  270. Wang J, et al. 2021. Am J Cancer Res. 11:2005. PubMed
  271. Wang F, et al. 2021. Neoplasia. 23:281. PubMed
  272. Guo X, et al. 2020. J Cell Mol Med. . PubMed
  273. Simoni L, et al. 2020. Cell Rep. 33:108330. PubMed
  274. Yu H, et al. 2015. PLoS One. 10: 0143001. PubMed
  275. Pan X, et al. 2019. BMC Complement Altern Med. 19:163. PubMed
  276. Li K, et al. 2020. Nat Commun. 0.795138889. PubMed
  277. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  278. Zukauskas A, et al. 2018. mSphere. 3:e00303. PubMed
  279. Mincham KT, et al. 2021. Front Immunol. 11:601494. PubMed
  280. Zheng Y, et al. 2022. Transl Res. :. PubMed
  281. Gawish R, et al. 2022. Elife. 11:. PubMed
  282. Li J, et al. 2022. Nat Commun. 13:1481. PubMed
  283. Roberto MP, et al. 2021. Immunity. 54(8):1807-1824.e14. PubMed
  284. Goldberg EL, et al. 2021. Cell Metabolism. :. PubMed
  285. Tanegashima K et al. 2017. EBioMedicine. 24:247-256 . PubMed
  286. Crowe J, et al. 2020. PLoS Pathog. 16:e1008391. PubMed
  287. Tur J, et al. 2020. Cell Reports. 32(8):108079. PubMed
  288. Sun Q, et al. 2022. J Inflamm Res. 15:5827. PubMed
  289. Cao Y, et al. 2022. Small. 18:e2203466. PubMed
  290. Li C, et al. 2022. Front Cell Dev Biol. 10:913824. PubMed
  291. Xu Z, et al. 2022. Cell Death Dis. 13:502. PubMed
  292. Pastor Arroyo EM, et al. 2022. Clin Sci (Lond). 136:557. PubMed
  293. Erens C, et al. 2022. Biomedicines. 10:. PubMed
  294. Zhang J, et al. 2021. Stem Cell Res Ther. 12:579. PubMed
  295. Gu Z, et al. 2021. Nat Genet. 53:672. PubMed
  296. Zuo S, et al. 2021. EBioMedicine. 64:103240. PubMed
  297. Zheng QY, et al. 2020. FASEB J. 34:10590. PubMed
  298. Li J, et al. 2021. eLife. 10:00. PubMed
  299. Trivedi S, et al. 2020. Elife. 9:00. PubMed
  300. Tripathi D, et al. 2016. Nat Commun. 7:13896. PubMed
  301. Fan X, et al. 2014. PLoS One. 9:107638. PubMed
  302. Martínez-Vicente P, et al. 2019. PLoS Pathog. 15:e1007658. PubMed
  303. Liu WL, et al. 2019. Nat Commun. 10:3199. PubMed
  304. Kubli SP, et al. 2019. Nat Commun. 10:2678. PubMed
RRID
AB_312661 (BioLegend Cat. No. 100203)
AB_312661 (BioLegend Cat. No. 100204)

Antigen Details

Structure
Ig superfamily, CD3/TCR, 20 kD
Distribution

Thymocytes (differentiation dependent), mature T cells, NK-T cells

Function
Antigen recognition, TCR signal transduction, T cell activation
Ligand/Receptor
Peptide antigen/MHC-complex
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Davis MM. 1990. Annu. Rev. Biochem. 59:475.
3. Weiss A, et al. 1994. Cell 76:263.

Gene ID
12502 View all products for this Gene ID
UniProt
View information about CD3 on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD3 Reagents Request Custom Conjugation
Description Clone Applications
FITC anti-mouse CD3 17A2 FC
PE anti-mouse CD3 17A2 FC
Purified anti-mouse CD3 17A2 FC,IHC-F,IP,ICC
Alexa Fluor® 647 anti-mouse CD3 17A2 FC,IHC-F,3D IHC,SB
Alexa Fluor® 488 anti-mouse CD3 17A2 FC,IHC-F,3D IHC
Pacific Blue™ anti-mouse CD3 17A2 FC
Alexa Fluor® 700 anti-mouse CD3 17A2 FC
PerCP/Cyanine5.5 anti-mouse CD3 17A2 FC
PE/Cyanine7 anti-mouse CD3 17A2 FC
APC/Cyanine7 anti-mouse CD3 17A2 FC
Brilliant Violet 421™ anti-mouse CD3 17A2 FC,ICC
Brilliant Violet 570™ anti-mouse CD3 17A2 FC
Brilliant Violet 650™ anti-mouse CD3 17A2 FC
Brilliant Violet 785™ anti-mouse CD3 17A2 FC
Brilliant Violet 510™ anti-mouse CD3 17A2 FC
APC anti-mouse CD3 17A2 FC
Ultra-LEAF™ Purified anti-mouse CD3 17A2 FC,IHC-F,IP,ICC
Brilliant Violet 605™ anti-mouse CD3 17A2 FC
Alexa Fluor® 594 anti-mouse CD3 17A2 IHC-F,FC,3D IHC,SB
Brilliant Violet 711™ anti-mouse CD3 17A2 FC
Biotin anti-mouse CD3 17A2 FC,IHC-F
PE/Dazzle™ 594 anti-mouse CD3 17A2 FC
APC/Fire™ 750 anti-mouse CD3 17A2 FC
Brilliant Violet 750™ anti-mouse CD3 17A2 FC
TotalSeq™-A0182 anti-mouse CD3 17A2 PG
TotalSeq™-B0182 anti-mouse CD3 17A2 PG
Spark Blue™ 550 anti-mouse CD3 17A2 FC
Spark NIR™ 685 anti-mouse CD3 17A2 FC
TotalSeq™-C0182 anti-mouse CD3 17A2 PG
APC/Fire™ 810 anti-mouse CD3 17A2 FC
PE/Fire™ 640 anti-mouse CD3 17A2 FC
Spark YG™ 570 anti-mouse CD3 17A2 IHC-F
PE/Fire™ 700 anti-mouse CD3 17A2 FC
PE/Cyanine5 anti-mouse CD3 17A2 FC
Spark Blue™ 574 anti-mouse CD3 Antibody 17A2 FC
Spark Violet™ 423 anti-mouse CD3 17A2 FC
PE/Fire™ 810 anti-mouse CD3 17A2 FC
Spark Red™ 718 anti-mouse CD3 17A2 FC
Spark UV™ 387 anti-mouse CD3 17A2 FC
Go To Top Version: 1    Revision Date: 11/30/2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account